An innovative startup was developing a breakthrough in-vitro diagnostic (IVD) solution aimed at improving cardiac disease diagnosis, risk stratification, and, potentially, better tailor treatment according to patients’ characteristics.
The client needed support to create an early go-to-market strategy for the novel IVD solution to prepare for product development and successful launch in key European countries and the United States (US). The client wanted a full and comprehensive understanding of the market landscape and dynamics, regulatory processes, pricing and market access, the current state of cardiovascular clinical practice, and commercial strategies.
The client selected Alira Health for this project based on the company’s capabilities and internal cross-functional synergies to strategically combine different areas of expertise, including clinical, regulatory, market access, and commercial.
The Alira Health team assessed the market, product value proposition, and client capabilities to develop a comprehensive and pragmatic early-go-to-market strategy with relevant scenarios for next steps.
Specifically, the Alira Health team:
All findings and recommendations were shared and discussed with the client across frequent touchpoints and brainstorming sessions. The value proposition of the IVD solution was also summarized into an ad-hoc pitch deck for potential investor/partner engagement.
With Alira Health’s help, the client gained a comprehensive understanding of the actions needed in the next four to five years to launch their product, considering their goals, milestones, and internal capabilities. The Alira Health team provided a report containing a comprehensive understanding of the market landscape, regulatory processes, pricing and market access dynamics, and commercialization strategies. The project helped increase the client’s awareness of the challenges and requirements involved in bringing their IVD product to market. The project also equipped the client with a powerful business case and pitch deck for investor, partner, and stakeholder conversations. This strengthened their position with a clear rationale and justification for their product development and commercialization strategy, making it easier to garner support and resources internally and externally.
The Alira Health team developed and clearly summarized all the relevant factors which will affect the future commercialization of the IVD product, providing a checklist of every aspect that this innovative startup must consider for a successful launch. The client greatly appreciated the Alira Health team’s methodology, including regular opportunities to engage and ask questions.
Key success factors included:
Learn more about market access, pricing and reimbursement support.
Subscribe to our newsletter for the latest news, events, and thought leadership